🕵️ Synergy CHC Corp. ($SNYR)
SEC insider & ownership activity, last 12 months · CIK 1562733 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. Knight Therapeutics Inc. added 17.0% → 19.9%. 5 red-flag 8-Ks in the window, most recently Delisting notice (3.01), Sep 11, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Knight Therapeutics Inc. | 19.9% | 13G | Jun 13, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Delisting notice (3.01) | Sep 11, 2026 | filing ↗ |
| Bankruptcy (1.03) | Sep 4, 2026 | filing ↗ |
| Officer/director changes (5.02) | Sep 4, 2026 | filing ↗ |
| Debt acceleration (2.04) | Aug 25, 2026 | filing ↗ |
| Delisting notice (3.01) | Aug 20, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 20, 2026 | filing ↗ |
| Debt acceleration (2.04) | Aug 11, 2026 | filing ↗ |
| Other events (8.01) | Jul 15, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 29, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 29, 2026 | filing ↗ |
| Delisting notice (3.01) | May 15, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Material agreement (1.01) | May 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 8, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 24, 2026 | filing ↗ |
| New financial obligation (2.03) | Mar 24, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 24, 2026 | filing ↗ |
| Other events (8.01) | Feb 27, 2026 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 22, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 22, 2025 | filing ↗ |